Third HLA-haploidentical stem cell transplantation using post-transplant cyclophosphamide for relapsed acute leukemia

Bone Marrow Transplant. 2023 Dec;58(12):1403-1405. doi: 10.1038/s41409-023-02108-y. Epub 2023 Sep 15.

Authors

Affiliations

¹ Hematology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. harada.naonori@omu.ac.jp.
² Department of Hematology, Fuchu Hospital, Osaka, Japan. harada.naonori@omu.ac.jp.
³ Hematology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.

PMID: 37714944
DOI: 10.1038/s41409-023-02108-y

No abstract available

Publication types

Letter

MeSH terms

Cyclophosphamide / therapeutic use
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute* / therapy

Substances

Cyclophosphamide